Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Jakavi“
Suchtreffer
Begriffe & Kennungen
Jakavi · 4.5 · CYP3A4 inducers (such as, but not limited to, avasimibe, carbamazepine, phenobarbital, phenytoin, rifabutin, r
Eintrag öffnenJakavi · 4.5 · CYP3A4 inhibitors Strong CYP3A4 inhibitors (such as, but not limited to, boceprevir, clarithromycin, indinavir
Eintrag öffnenJakavi · 4.5 · CYP3A4 inhibitors Strong CYP3A4 inhibitors (such as, but not limited to, boceprevir, clarithromycin, indinavir
Eintrag öffnenJakavi · 4.5 · Dual CYP2C9 and CYP3A4 inhibitors In healthy subjects co-administration of ruxolitinib (10 mg single dose) wit
Eintrag öffnenJakavi · 4.5 · Effects of ruxolitinib on other medicinal products
Eintrag öffnenJakavi · 4.5 · Effects of ruxolitinib on other medicinal products
Eintrag öffnenJakavi · 4.5 · Enzyme inducers
Eintrag öffnenJakavi · 4.5 · In healthy subjects given ruxolitinib (50 mg single dose) following the potent CYP3A4 inducer rifampicin (600
Eintrag öffnenJakavi · 4.5 · In healthy subjects given ruxolitinib (50 mg single dose) following the potent CYP3A4 inducer rifampicin (600
Eintrag öffnenJakavi · 4.5 · Interaction studies have only been performed in adults.
Eintrag öffnenJakavi · 4.5 · Interaction studies have only been performed in adults.
Eintrag öffnenJakavi · 4.5 · Interactions resulting in dose reduction of ruxolitinib
Eintrag öffnenJakavi · 4.5 · Interactions resulting in dose reduction of ruxolitinib
Eintrag öffnenJakavi · 4.5 · It is possible that the potential inhibition of P-gp and BCRP in the intestine can be minimised if the time be
Eintrag öffnenJakavi · 4.5 · It is possible that the potential inhibition of P-gp and BCRP in the intestine can be minimised if the time be
Eintrag öffnenJakavi · 4.5 · Mild or moderate CYP3A4 inhibitors (such as, but not limited to, ciprofloxacin, erythromycin, amprenavir, ataz
Eintrag öffnenJakavi · 4.5 · Mild or moderate CYP3A4 inhibitors (such as, but not limited to, ciprofloxacin, erythromycin, amprenavir, ataz
Eintrag öffnenJakavi · 4.5 · No dose adjustment is recommended when ruxolitinib is co-administered with mild or moderate CYP3A4 inhibitors
Eintrag öffnenJakavi · 4.5 · No dose adjustment is recommended when ruxolitinib is co-administered with mild or moderate CYP3A4 inhibitors
Eintrag öffnenJakavi · 4.5 · Other interactions to be considered affecting ruxolitinib
Eintrag öffnen